- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03243279
BRS and Outcomes in Cardiothoracic Surgery
July 20, 2022 updated by: Duke University
Role of Preoperative Baroreflex Sensitivity on Major Outcomes After Cardiothoracic Surgery
The purpose of this study is to determine whether baroreceptor sensitivity (the ability of your body to change your heart rate and/or blood pressure in response to a situation) has any effect on how likely you are to suffer certain events after heart or lung surgery.
The postoperative events that the investigators will be studying are pain after surgery, atrial fibrillation (an irregular heart rhythm), and cognitive dysfunction (a decline in mental abilities).
Study Overview
Status
Completed
Detailed Description
The purpose of this study is to determine if preoperative baroreceptor sensitivity (BRS) correlates with major outcomes after cardiac and thoracic surgery, including acute and chronic pain, atrial arrhythmias, and cognitive function.
To test this hypothesis, approximately 95 patients will be enrolled, and spontaneous baroreceptor sensitivity will be measured prior to surgery as well as immediately postoperatively.
Outcomes will include acute pain using the numeric rating scale, Brief Pain Inventory, and Gracely Box Scale administered preoperatively, on postoperative days 1 and 2 and by phone at 6-weeks postoperatively.
Chronic pain will be assessed at 6-month follow-up visit via hyperalgesia testing using Von Frey filaments.
Postoperative atrial arrhythmias will be assessed by review of postoperative telemetry, the electronic medical record, and ECG performed prior to discharge.
Finally, cognitive function will be assess via Mini-Mental State examination administered preoperative and at the 6-month follow-up visit.
Association between BRS and the outcomes of interest will be tested with regression models adjusted for appropriate covariates.
Significance threshold alpha will be adjusted for the number of statistical tests using the Bonferroni correction.
Our hypothesis is that patients with impaired preoperative BRS will have an increased incidence of acute and chronic postoperative pain, atrial fibrillation, and cognitive decline after surgery.
Study Type
Observational
Enrollment (Actual)
72
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients presenting for cardiac and thoracic surgery at Duke University Hospital, a quaternary referral center
Description
Inclusion Criteria:
- >= 18 years of age
- Undergoing cardiac (coronary artery bypass grafting [CABG], CABG + valve, or valve only) or thoracic (video-assisted thoracoscopic [VATS] approach to lobectomy) surgery
Exclusion Criteria:
- Any preexisting pain condition (defined as pain of >=3 months duration prior to enrollment)
- Pain at the time of enrollment interview
- Need for preoperative analgesics
- Preexisting chronic or paroxysmal atrial fibrillation
- Preexisting atrial or ventricular arrhythmia
- Need for preoperative anti-arrhythmic medication
- History of symptomatic cerebrovascular disease (e.g., prior stroke) with residual deficits
- Alcoholism (>2 drinks/day)
- Psychiatric illness (any clinical diagnosis requiring therapy)
- Drug abuse (any illicit drug use in the preceding 3 months before surgery)
- Hepatic insufficiency (liver function tests > 1.5 times the upper limit of normal)
- Severe pulmonary insufficiency (home oxygen)
- Renal failure (serum creatinine >2.0 mg/dL)
- Non-English speaking
- Unable to read
- Participants who score <24 on baseline Mini Mental State examination
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Surgical
No interventions.
Patients undergoing cardiothoracic surgery will be assessed for baroreflex sensitivity and the outcomes of interest.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline baroreflex sensitivity
Time Frame: 30 min
|
Non-invasive BRS testing with BIOPAC MP160
|
30 min
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative day (POD) 1 baroreflex sensitivity
Time Frame: 30 min
|
Non-invasive BRS testing with BIOPAC MP160
|
30 min
|
POD 2 baroreflex sensitivity
Time Frame: 30 min
|
Non-invasive BRS testing with BIOPAC MP160
|
30 min
|
6 month baroreflex sensitivity
Time Frame: 6 months
|
Non-invasive BRS testing with BIOPAC MP160
|
6 months
|
Acute postoperative pain as assessed by the numeric rating scale (NRS) - 24h
Time Frame: 24 hours
|
Median NRS pain score in the first 24h after surgery
|
24 hours
|
Acute postoperative pain as assessed by the numeric rating scale (NRS) - 48h
Time Frame: 48 hours
|
Median NRS pain score in the second 24h after surgery
|
48 hours
|
Acute postoperative pain as assessed by the Gracely Box Scale (GBS) - POD1
Time Frame: 15 min
|
GBS survey on POD 1
|
15 min
|
Acute postoperative pain as assessed by the Gracely Box Scale (GBS) - POD2
Time Frame: 15 min
|
GBS survey on POD 2
|
15 min
|
Acute postoperative pain as assessed by the Gracely Box Scale (GBS) - 6 mo
Time Frame: 6 months
|
GBS survey at 6 month follow-up visit
|
6 months
|
Chronic pain as assessed by the change in Brief Pain Inventory score
Time Frame: Baseline, 6 months
|
Change from baseline to 6 months postoperatively
|
Baseline, 6 months
|
Hyperalgesia
Time Frame: 6 months
|
Nociceptive threshold as assessed by Von Frey filament testing at 6 month follow-up
|
6 months
|
Area of hyperalgesia or allodynia
Time Frame: 6 months
|
Area surrounding operative incision as assessed by Von Frey filament testing at 6 month follow-up
|
6 months
|
Postoperative atrial fibrillation
Time Frame: 6 weeks
|
Chart review assessment of the occurrence of postoperative atrial fibrillation during hospitalization and up to 6 weeks postoperatively
|
6 weeks
|
Postoperative cognitive change
Time Frame: Baseline, 6 months
|
Change from baseline to 6 months in the Mini Mental Status Exam score
|
Baseline, 6 months
|
Baseline psychological distress
Time Frame: 15 min
|
As assessed by the Brief Symptom Inventory-18
|
15 min
|
6 month psychological distress
Time Frame: 6 months
|
As assessed by the Brief Symptom Inventory-18
|
6 months
|
Baseline frailty
Time Frame: 10 min
|
As assessed by the Modified Frailty Index
|
10 min
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2017
Primary Completion (Actual)
December 15, 2021
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
August 2, 2017
First Submitted That Met QC Criteria
August 3, 2017
First Posted (Actual)
August 8, 2017
Study Record Updates
Last Update Posted (Actual)
July 21, 2022
Last Update Submitted That Met QC Criteria
July 20, 2022
Last Verified
February 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00083136
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown